Clearside Biomedical logo

Clearside Biomedical share price today

(CLSD)

Clearside Biomedical share price is $0.95 & ₹81.37 as on 1 Jan 2025, 2.30 'hrs' IST

$0.95

-0.04

(-4.5%)

Market is closed - opens 8 PM, 02 Jan 2025

View live Clearside Biomedical share price in Dollar and Rupees. Guide to invest in Clearside Biomedical from India. Also see the sentimental analysis on Indian investors investing in Clearside Biomedical. Get details on the Indian mutual funds that are investing in Clearside Biomedical. Get Analyst recommendations and forecasts along with all the Clearside Biomedical's financials.

Clearside Biomedical share price movements

  • Today's Low: $0.94
    Today's High: $1.00

    Day's Volatility :5.99%

  • 52 Weeks Low: $0.80
    52 Weeks High: $2.12

    52 Weeks Volatility :62.22%

Clearside Biomedical Returns

PeriodClearside Biomedical IncSector (Health Care)Index (Russel 2000)
3 Months
-28.57%
-10.0%
0.0%
6 Months
-25.78%
-4.7%
0.0%
1 Year
-34.48%
-0.9%
0.0%
3 Years
-67.01%
-2.4%
-21.2%

Clearside Biomedical Key Statistics

in dollars & INR

Previous Close
$0.9948
Open
$1.0
Today's High
$1.0
Today's Low
$0.94005
Market Capitalization
$72.1M
Today's Volume
$316.2K
52 Week High
$2.12
52 Week Low
$0.801
Revenue TTM
$7.5M
EBITDA
$-25.7M
Earnings Per Share (EPS)
$-0.45
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1310.02%

How to invest in Clearside Biomedical from India?

It is very easy for Indian residents to invest directly in Clearside Biomedical from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Clearside Biomedical stock in both Indian Rupees (INR) and US Dollars (USD). Search for Clearside Biomedical or CLSD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Clearside Biomedical or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Clearside Biomedical shares which would translate to 0.902 fractional shares of Clearside Biomedical as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Clearside Biomedical, in just a few clicks!

Returns in Clearside Biomedical for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Clearside Biomedical investment value today

Current value as on today

₹68,384

Returns

₹31,616

(-31.62%)

Returns from Clearside Biomedical Stock

₹34,483 (-34.48%)

Dollar Returns

₹2,867 (+2.87%)

Indian investors sentiment towards Clearside Biomedical

77%

Period: Oct 3, 2024 to Jan 1, 2025. Change in 30 Days versus previous period

Search volume for Clearside Biomedical on INDmoney from India has grown in the last 30 days as on Jan 2, 2025. 77% more investors are searching Clearside Biomedical in the last 30 days versus the previous period.

Global Institutional Holdings in Clearside Biomedical

  • Vanguard Group Inc

    3.74%

  • Carmignac Gestion

    2.55%

  • BlackRock Inc

    1.05%

  • Renaissance Technologies Corp

    0.98%

  • Geode Capital Management, LLC

    0.96%

  • First Manhattan Co. LLC

    0.88%

Analyst Recommendation on Clearside Biomedical

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Clearside Biomedical(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Clearside Biomedical

What analysts predicted

Upside of 531.58%

Current:

$0.95

Target:

$6.00

Insights on Clearside Biomedical

  • Price Movement

    In the last 7 days, CLSD stock has moved up by 2.2%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 90.0K → 1.03M (in $), with an average increase of 91.3% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -7.59M → -7.68M (in $), with an average decrease of 1.2% per quarter
  • CLSD vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 20.7% return, outperforming this stock by 47.1%
  • CLSD vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 38.8% return, outperforming this stock by 104.3%
  • Price to Sales

    ForCLSD every $1 of sales, investors are willing to pay $8.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Clearside Biomedical Financials in INR & Dollars

FY18Y/Y Change
Revenue
$30.0K
↓ 91.3%
Net Income
$-82.8M
↑ 40.43%
Net Profit Margin
-276.1K%
↓ 258965.8%
FY19Y/Y Change
Revenue
$2.2M
↑ 7143.33%
Net Income
$-30.6M
↓ 63.1%
Net Profit Margin
-1.4K%
↑ 274653.7%
FY20Y/Y Change
Revenue
$7.9M
↑ 263.28%
Net Income
$-18.0M
↓ 41.0%
Net Profit Margin
-228.4%
↑ 1177.9%
FY21Y/Y Change
Revenue
$29.6M
↑ 274.65%
Net Income
$376.0K
↓ 102.09%
Net Profit Margin
1.27%
↑ 229.67%
FY22Y/Y Change
Revenue
$1.3M
↓ 95.51%
Net Income
$-34.1M
↓ 9161.53%
Net Profit Margin
-2.6K%
↓ 2568.82%
FY23Y/Y Change
Revenue
$8.2M
↑ 519.89%
Net Income
$-32.5M
↓ 4.66%
Net Profit Margin
-394.91%
↑ 2172.64%
Q2 FY23Q/Q Change
Revenue
$1.0M
↑ 25350.0%
Net Income
$-9.1M
↓ 30.61%
Net Profit Margin
-894.5%
↑ 327155.5%
Q3 FY23Q/Q Change
Revenue
$859.0K
↓ 15.62%
Net Income
$-9.3M
↑ 1.77%
Net Profit Margin
-1.1K%
↓ 184.31%
Q4 FY23Q/Q Change
Revenue
$6.3M
↑ 638.65%
Net Income
$-4.8M
↓ 47.86%
Net Profit Margin
-76.15%
↑ 1002.66%
Q1 FY24Q/Q Change
Revenue
$230.0K
↓ 96.38%
Net Income
$-11.8M
↑ 143.44%
Net Profit Margin
-5.1K%
↓ 5038.2%
Q2 FY24Q/Q Change
Revenue
$90.0K
↓ 60.87%
Net Income
$-7.6M
↓ 35.44%
Net Profit Margin
-8.4K%
↓ 3323.43%
Q3 FY24Q/Q Change
Revenue
$1.0M
↑ 1053.33%
Net Income
$-7.7M
↑ 1.24%
Net Profit Margin
-740.66%
↑ 7697.12%
FY18Y/Y Change
Profit
$30.0K
↓ 91.3%
FY19Y/Y Change
Profit
$2.2M
↑ 7143.33%
FY20Y/Y Change
Profit
$7.9M
↑ 263.28%
FY21Y/Y Change
Profit
$29.4M
↑ 272.4%
FY22Y/Y Change
Profit
$1.1M
↓ 96.18%
FY23Y/Y Change
Profit
$7.9M
↑ 600.89%
Q2 FY23Q/Q Change
Profit
$805.0K
↓ 7418.18%
Q3 FY23Q/Q Change
Profit
$717.0K
↓ 10.93%
Q4 FY23Q/Q Change
Profit
$6.3M
↑ 782.15%
Q1 FY24Q/Q Change
Profit
$202.0K
↓ 96.81%
Q2 FY24Q/Q Change
Profit
$90.0K
↓ 55.45%
Q3 FY24Q/Q Change
Profit
$1.0M
↑ 1053.33%
FY18Y/Y Change
Operating Cash Flow
$-79.2M
↑ 55.04%
Investing Cash Flow
$-3.8M
↓ 118.69%
Financing Cash Flow
$81.8M
↑ 1425.16%
FY19Y/Y Change
Operating Cash Flow
$-27.1M
↓ 65.82%
Investing Cash Flow
$32.9M
↓ 975.66%
Financing Cash Flow
$8.7M
↓ 89.37%
FY20Y/Y Change
Operating Cash Flow
$-13.1M
↓ 51.53%
Investing Cash Flow
$-55.0K
↓ 100.17%
Financing Cash Flow
$7.9M
↓ 9.52%
FY21Y/Y Change
Operating Cash Flow
$-10.7M
↓ 18.19%
Investing Cash Flow
$-246.0K
↑ 347.27%
Financing Cash Flow
$23.8M
↑ 202.3%
FY22Y/Y Change
Operating Cash Flow
$-13.4M
↑ 24.52%
Investing Cash Flow
$-246.0K
↑ 0.0%
Financing Cash Flow
$31.3M
↑ 31.75%
Q2 FY23Q/Q Change
Operating Cash Flow
$-5.3M
↓ 26.01%
Investing Cash Flow
$-1.1M
↑ 853.91%
Financing Cash Flow
$22.0K
↓ 93.37%

Clearside Biomedical Technicals Summary

Sell

Neutral

Buy

Clearside Biomedical is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Clearside Biomedical Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Clearside Biomedical Inc
-12.04%
-25.78%
-34.48%
-67.01%
-82.76%
Regeneron Pharmaceuticals, Inc.
-4.97%
-31.12%
-22.37%
13.59%
91.62%
Biontech Se
-1.42%
42.28%
3.53%
-50.85%
155.61%
Alnylam Pharmaceuticals, Inc.
-6.56%
-6.26%
23.43%
35.31%
102.91%
Vertex Pharmaceuticals Incorporated
-11.88%
-15.14%
-1.95%
80.96%
79.75%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Clearside Biomedical Inc
133.0
NA
0.0
-0.47
-13.1
-0.44
NA
-0.25
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Clearside Biomedical Inc
Buy
$72.1M
-82.76%
133.0
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
91.62%
17.61
33.61%
Biontech Se
Buy
$27.3B
155.61%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
102.91%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
79.75%
32.84
-4.51%

About Clearside Biomedical

clearside biomedical, inc. is a pharmaceuticals company located in 1220 old alpharetta rd., suite 300, alpharetta, ga, united states.
Organization
Clearside Biomedical
Employees
30
CEO
Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D.
Industry
Health Technology

Management People of Clearside Biomedical

NameTitle
Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D.
President, CEO & Director
Mr. Charles A. Deignan
Chief Financial Officer
Ms. Jenny R. Kobin
Head of Investor Relations
Mr. Rick McElheny
Senior Vice President of Corporate Development & Alliance Management
Mr. Rafael V. Andino
Senior Vice President of Engineering & Manufacturing
Ms. Susan L. Coultas Ph.D.
Chief Clinical Officer
Dr. Ngai Hang Chong FRCOphth, FRCS, M.B.A., M.D.
Chief Medical Officer

Important FAQs about investing in Clearside Biomedical from India :

What is Clearside Biomedical share price today?

Clearside Biomedical share price today stands at $0.95, Open: $1.00 ; Previous Close: $0.99 ; High: $1.00 ; Low: $0.94 ; 52 Week High: $2.12 ; 52 Week Low: $0.80. The stock opens at $1.00, after a previous close of $0.99. The stock reached a daily high of $1.00 and a low of $0.94, with a 52-week high of $2.12 and a 52-week low of $0.80.

Can Indians buy Clearside Biomedical shares?

Yes, Indians can invest in the Clearside Biomedical (CLSD) from India.

With INDmoney, you can buy Clearside Biomedical at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Clearside Biomedical at zero transaction cost.

How can I buy Clearside Biomedical shares from India?

It is very easy to buy Clearside Biomedical from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Clearside Biomedical be purchased?

Yes, you can buy fractional shares of Clearside Biomedical with INDmoney app.

What are the documents required to start investing in Clearside Biomedical stocks?

To start investing in Clearside Biomedical, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Clearside Biomedical

Today’s highest price of Clearside Biomedical (CLSD) is $1.00.

Today’s lowest price of Clearside Biomedical (CLSD) is $0.94.

What is today's market capitalisation of Clearside Biomedical

Today's market capitalisation of Clearside Biomedical CLSD is 72.1M

What is the 52 Week High and Low Range of Clearside Biomedical

  • 52 Week High

    $2.12

  • 52 Week Low

    $0.80

What are the historical returns of Clearside Biomedical?

  • 1 Month Returns

    -12.04%

  • 3 Months Returns

    -25.78%

  • 1 Year Returns

    -34.48%

  • 5 Years Returns

    -82.76%

Who is the Chief Executive Officer (CEO) of Clearside Biomedical

Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D. is the current Chief Executive Officer (CEO) of Clearside Biomedical.